A new chapter in regenerative medicine, biologics and advanced med device manufacturing has begun as Netherlands-based Hummingbird Biomedical, in partnership with DEMCON Life Sciences, officially opens its U.S. headquarters and advanced manufacturing lab, joining other organizations located on the Mayo Clinic Scottsdale campus, a leading destination for complex care.
This state-of-the-art global scale-up venture studio and Hummingbird landing lab positions Scottsdale at the heart of next-generation health innovation. Designed as a soft-landing and scale-up gateway for high-potential life sciences ventures from Europe and Asia, the facility offers a fast-track into the U.S. market. Startups that graduate from the lab will accelerate their journey from concept to commercialization.
“Hummingbird accelerates the expansion of breakthrough therapies through its hub-and-spoke venture-scaling platform, connecting startups with scalable manufacturing, clinical assets, market-entry pathways and funding,” said Hummingbird Biomedical founder and CEO Dr. Marianne van der Steen. “By bridging the gap between lab innovation and real-world healthcare adoption, companies move faster from concept to global impact — while bringing life-changing technologies to patients faster.”…